1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
Species | Cynomolgus |
Synonyms | CLEC12A, MICL, CLL-1, CLL1, DCAL2, DCAL-2, CD371 |
Accession | A0A2K5WXQ6 |
Amino Acid Sequence | His32-Ala232, with C-terminal His |
Expression System | HEK293 |
Molecular Weight | 35-45kDa (Reducing) |
Purity | >95% by SDS-PAGE & RP-HPLC |
Endotoxin | <0.1EU/μg |
Conjugation | Unconjugated |
Tag | His Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer | PBS, pH7.4, 5% trehalose |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage |
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Reference | Lahoud M H. et al. (2009) The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J Immunol. 182(12): 7587-7594. |
Background
Clec12a (also called myeloid inhibitory C-type lectin-like receptor, MICL) was originally described as an ITIM-containing inhibitory CLR expressed by human granulocytes and monocytes. It was suggested that Clec12a recognizes some endogenous ligands as soluble Clec12a could bind to single-cell suspensions isolated from various murine tissues. CLEC12A is a myeloid lineage antigen that is highly expressed by AML cells and LSCs, but not expressed by normal hematopoietic stem cells (HSCs), thus minimizing off-target toxicity.
Picture
Picture
SDS-PAGE
ELISA

Immobilized CLEC12A/MICL His Tag Protein, Cynomolgus (Cat. No. UA011058) at 2.0μg/mL (100μL/well) can bind CLEC12A Rabbit pAb (A6250) with EC50 of 0.068-0.12 μg/mL.
